FDA Drug recall D-1542-2020
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
- FDA Drug
- Class II
- terminated
- Published 2020-09-02
On 2020-09-02 the FDA classified a Class II recall of BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01 by Par Pharmaceutical, citing failed Impurity /Degradation Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1542-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-08-10 |
| Published | 2020-09-02 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Par Pharmaceutical |
| Distribution | US |
Product
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Reason
Failed Impurity /Degradation Specifications
Identifiers
| code_info | Lot # 32091002, exp. date May 2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1542-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.